Exactus Financials

Based on the key indicators related to Exactus' liquidity, profitability, solvency, and operating efficiency, Exactus is not in a good financial situation at the moment. It has a very high risk of going through financial straits in June.
With this module, you can analyze Exactus financials for your investing period. You should be able to track the changes in Exactus individual financial statements over time to develop the understanding of its risk, liquidity, profitability, or other critical and vital indicators.
  
Understanding current and past Exactus Financials, including the trends in assets, liabilities, equity and income are directly related to making proper and timely investing decisions. All of Exactus' financial statements are interrelated, with each one affecting the others. For example, an increase in Exactus' assets may result in an increase in income on the income statement.
The data published in Exactus' official financial statements usually reflect Exactus' business processes, product offerings, services, and other fundamental events. But there are other numbers, ratios, or fundamental indicators derived from these statements that are easier to understand and visualize within the underlying realities that drive quantitative information of Exactus. For example, before you start analyzing numbers published by Exactus accountants, it's critical to develop an understanding of what Exactus' liquidity, profitability, and earnings quality are in the context of the Healthcare space in which it operates.
Please note, the presentation of Exactus' financial position, as portrayed in its financial statements, is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, Exactus' management is honest, while the outside auditors are strict and uncompromising. Whatever the case, the imprecision that can be found in Exactus' accounting process means that the reasonable investor should take a skeptical approach toward the financial statement analysis of Exactus. Please utilize our Beneish M Score to check the likelihood of Exactus' management manipulating its earnings.

Exactus Stock Summary

Exactus competes with NETGEAR, Calliditas Therapeutics, Emerson Radio, Uber Technologies, and Minerals Technologies. Exactus, Inc. develops and sells cannabidiol and hemp-derived products. The company was incorporated in 2008 and is based in Greenwood Village, Colorado. Exactus is traded on OTC Exchange in the United States.
InstrumentUSA OTC Stock View All
ExchangeOTCQB Exchange
ISINUS30066P2011
Business Address5910 South University
SectorHealthcare
IndustryDrug Manufacturers—Specialty & Generic
BenchmarkNYSE Composite
Websitewww.exactushemp.com
Phone800 985 0515
CurrencyUSD - US Dollar
You should never invest in Exactus without having analyzed its financial statements. Do not rely on someone else's analysis or guesses about the future performance of Exactus OTC Stock, because this is throwing your money away. Analyzing the key information contained in Exactus' financial statements can give you an edge over other investors and help to ensure that your investments perform well for you.

Exactus Key Financial Ratios

Generally speaking, Exactus' financial ratios allow both analysts and investors to convert raw data from Exactus' financial statements into concise, actionable information that can be used to evaluate the performance of Exactus over time and compare it to other companies across industries. There are many critical financial ratios that investors are exposed to on a daily basis, but they are usually grouped into few meaningful categories from each financial statement that Exactus reports annually and quarterly.

Exactus Financial Ratios Relationships

Comparative valuation techniques use various fundamental indicators to help in determining Exactus's current stock value. Our valuation model uses many indicators to compare Exactus value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Exactus competition to find correlations between indicators driving Exactus's intrinsic value. More Info.
Exactus is one of the top stocks in return on equity category among related companies. It is one of the top stocks in return on asset category among related companies . Comparative valuation analysis is a catch-all model that can be used if you cannot value Exactus by discounting back its dividends or cash flows. This model doesn't attempt to find an intrinsic value for Exactus' OTC Stock. Still, instead, it compares the stock's price multiples to a benchmark or nearest competition to determine if the stock is relatively undervalued or overvalued. The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Exactus' earnings, one of the primary drivers of an investment's value.
Check out Investing Opportunities to better understand how to build diversified portfolios. Also, note that the market value of any otc stock could be tightly coupled with the direction of predictive economic indicators such as signals in unemployment.
Note that the Exactus information on this page should be used as a complementary analysis to other Exactus' statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Comparator module to compare the composition, asset allocations and performance of any two portfolios in your account.

Other Consideration for investing in Exactus OTC Stock

If you are still planning to invest in Exactus check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Exactus' history and understand the potential risks before investing.
Price Exposure Probability
Analyze equity upside and downside potential for a given time horizon across multiple markets
Bond Analysis
Evaluate and analyze corporate bonds as a potential investment for your portfolios.
Pattern Recognition
Use different Pattern Recognition models to time the market across multiple global exchanges
Equity Valuation
Check real value of public entities based on technical and fundamental data
Funds Screener
Find actively-traded funds from around the world traded on over 30 global exchanges
Competition Analyzer
Analyze and compare many basic indicators for a group of related or unrelated entities
Financial Widgets
Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets
Sync Your Broker
Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors.
Portfolio Manager
State of the art Portfolio Manager to monitor and improve performance of your invested capital
Odds Of Bankruptcy
Get analysis of equity chance of financial distress in the next 2 years